Value-based insurance design

Last updated

Value-based insurance design (also V-BID, VBID, evidence-based benefit design, or value-based benefit design) is a demand-side approach to health policy reform. V-BID generally refers to health insurers' efforts to structure enrollee cost-sharing and other health plan design elements to encourage enrollees to consume high-value clinical services – those that have the greatest potential to positively impact enrollee health. [1] V-BID also discourages the use of low-value clinical services – when benefits do not justify the cost. [2] V-BID aims to increase health care quality and decrease costs by using financial incentives to promote cost efficient health care services and consumer choices. [3] V-BID health insurance plans are designed with the tenets of "clinical nuance" in mind. [4] These tenets recognize that medical services differ in the amount of health produced, and the clinical benefit derived from a specific service depends on the consumer using it, as well as when and where the service is provided. [4]

Contents

The basic V-BID premise is to align patients' out-of-pocket costs, such as copayments and premiums, with the value of health services. By reducing barriers to high-value treatments (through lower costs to patients) and discouraging low-value treatments (through higher costs to patients), V-BID plans may achieve improved health outcomes at any level of health care expenditure. Studies have shown that when barriers are reduced, significant increases in patient compliance with recommended treatments and potential cost savings result. [5] [6] [7]

History

Value-based benefit design

The concept of value-based benefit design (VBBD) arose in the 1990s. In 1993, Jack Mahoney and David Hom of Pitney Bowes pushed to move health forward in their workforce by removing barriers to access in mental health services and establishing on-site services and educational programs. [8] The company began reducing drug copays as a means to reducing the cost barrier that is often found with medications to treat chronic conditions. [8] In 1996, Asheville, North Carolina, began a community-based medication management program for self-insured employers to address diabetes in their workforce. [9] The initiative elevated the role of the pharmacists and reimbursed them for the time they spent educating and counseling diabetic patients. [9] This service required no out-of-pocket cost from the health care consumer and resulted in better health outcomes as well as direct and indirect cost savings. [9]

Benefit-based copay

In the late 1990s, researchers, physicians, and economists at the University of Michigan (U-M) began studying a concept similar to VBBD, something termed "benefit-based copay". In 2001, the team at U-M published on the concept of benefit-based copays in The American Journal of Managed Care . [10] The benefit-based copayment model aligned a patient's payment for a drug with how much benefit he or she derived from the medication – specifically, it placed consumers with established medical need on the lowest formulary tier. [11] [12] In 2004, the U-M benefit-based copay model was highlighted in an article in The Wall Street Journal . [11]

Value-based insurance design

Building on their work on the benefit-based copay model, the U-M team, led by A. Mark Fendrick, MD, and Michael Chernew, PhD, coined the term "value-based insurance design" and in 2005 founded the Center for Value-Based Insurance Design. [13] Much like VBBD and benefit-based copays, V-BID is built on the principle of lowering or removing financial barriers to essential, high-value clinical services. [4] V-BID aims to align patients' out-of-pocket costs, such as copayments, with the value of services. [4]

The term "value-based insurance design" was subsequently published for the first time in peer-reviewed literature in a 2006 article in The American Journal of Managed Care. [14] V-BID has since been included in legislation (including the Affordable Care Act) and numerous public and private sector health plans.

Purpose

Value-based insurance design aims to increase health care quality and decrease costs by using financial incentives to promote cost efficient health care services and consumer choices. [3] Health benefit plans can be designed to reduce barriers to maintaining and improving health. [3] By covering preventive services, wellness visits and treatments such as medications to control blood pressure or diabetes at low to no cost, V-BID plans may save money by reducing future expensive medical procedures. [3] V-BID plans may create disincentives as well, such as high cost-sharing, for health choices that may be unnecessary or repetitive, or when the same outcome can be achieved at a lower cost. [3] To decide what procedures are the most effective and cost efficient, insurance companies may use evidence-based data to design their plans. [3]

V-BID programs lower or eliminate cost sharing for efficient and effective treatments proven to keep people healthy. [15] This includes effective prevention and chronic care therapies, where research shows even modest cost sharing can keep people from getting care they need. [15] Lower cost sharing improves adherence to high-value care, which can help prevent future expensive complications. [15] V-BID programs increase cost sharing for unproven, misused or low-benefit care, like inappropriate emergency department use or imaging for low back pain. [15] This encourages people to consider alternatives and works especially well with "shared decision-making" tools that explain treatment option pros and cons objectively in plain language. [15]

Value-based insurance design advocates that copayment rates be set based on the value of clinical services (benefits and costs) – not exclusively the costs. [2] Recognizing that the value of an intervention varies depending on who receives it, who provides it, and where it is provided, more efficient resource allocation can be achieved when the amount of patient cost sharing is a function of the value that the specific service provides to the specific patient. [2]

Notable implementation

Federal and state policy

Affordable Care Act Section 2713 (c)

V-BID principles were incorporated into the Patient Protection and Affordable Care Act of 2010 (sometimes known as "Obamacare"). Specifically, V-BID was included in section 2713 (c). [16] Section 2713 of the Act requires that all health plans include certain preventive services without a copayment for the patient. Section 2713 (c) states:

"VALUE-BASED INSURANCE DESIGN.—The Secretary may develop guidelines to permit a group health plan and a health insurance issuer offering group or individual health insurance coverage to utilize value-based insurance designs." [17]

In September 2010, the Secretary of Health and Human Services (HHS) issued guidelines [18] for implementing health reform in the Affordable Care Act, including guidelines for V-BID implementation.

Connecticut Health Enhancement Program

In 2011 Connecticut implemented the Health Enhancement Program for state employees. [19] This voluntary program followed the principles of value-based insurance design by lowering patient costs for certain high-value primary and chronic disease preventive services, coupled with requirements that enrollees receive these services. [19] Nonparticipants in the program, including those removed for noncompliance with its requirements, were assessed a premium surcharge. [19] The program was created to curb cost growth and improve health through adherence to evidence-based preventive care. [19]

A 2016 evaluation [19] found that in the first two years of the program, utilization of recommended services increased, medication adherence improved, and emergency room utilization decreased, relative to control populations in other states.

Michigan Medicaid expansion

In September 2013, Michigan became the 25th state in the nation to expand Medicaid under the Affordable Care Act. [20] The expansion created the Healthy Michigan Plan, which relies on V-BID to improve access, control costs, and enhance personal responsibility. [21] Examples of V-BID principles in the expansion legislation include:

  • Section 105D(1)(e): Health plans are permitted to waive consumer copayments, "to promote greater access to services that prevent the progression and complications related to chronic diseases." [22]
  • Section 105D(1)(f): The Michigan Department of Community Health (MDCH) is assigned to "design and implement a copay structure that encourages the use of high-value services, while discouraging low-value services such as non-urgent Emergency Department utilization." [22]
  • Section 105D(5): The MDCH is assigned to, "implement a pharmaceutical benefit that utilizes copays at appropriate levels allowable by CMS to encourage the use of high-value, low cost prescriptions." [22]

Medicare Advantage (2017 V-BID Model Test)

In 2015, the Centers for Medicare and Medicaid Services announced plans to run a V-BID demonstration project in Medicare Advantage. [23] The test will occur in 7 states, is slated to start in 2017, and will run for 5 years. [23] Medicare Advantage plans (sometimes known as Medicare Part C plans) provide Medicare Part A and B benefits but utilize commercial insurance companies, not CMS, for claims. The model will test whether the introduction of clinically nuanced V-BID elements into Medicare Advantage plans' benefit designs will lead to higher-quality and more cost-efficient care for targeted enrollees. [23]

Private implementation

Pitney Bowes

One of the earliest implementations of the V-BID concept occurred in the 1990s at Pitney Bowes. The Wall Street Journal ran an article. [24] in 2004 detailing the Fortune 500 company's implementation of V-BID principles into their employee health-insurance plans. Pitney Bowes experienced a $1 million savings from reduced complications after lowering copayments for asthma and diabetes medication. [11] [12]

In 2007, Pitney Bowes eliminated copayments for cholesterol-lowering statins for its employees and beneficiaries with diabetes or vascular disease and lowered copayments for all employees and beneficiaries prescribed the clot-inhibiting drug clopidogrel. [25] The policy was associated with an immediate 2.8 percent increase in adherence to statins relative to controls. [25] For clopidogrel, the policy was associated with an immediate stabilizing of the adherence rate and a four-percentage-point difference between intervention and control subjects a year later. [25]

Mayo Clinic

In 2004, Mayo Clinic's self-funded health plan increased cost sharing for its employees and their dependents for specialty care visits and other services such as imaging, testing and outpatient procedures. [26] The plan also removed all cost sharing for visits to primary care providers and for preventive services such as colorectal screening and mammography. [26] The result was large decreases in the use of diagnostic testing and outpatient procedures that were sustained for four years, and an immediate decrease in the use of imaging. [26] Beneficiaries decreased visits to specialists but did not make greater use of primary care services. [26]

Novartis

on January 1, 2005, Novartis Pharmaceuticals implemented a value-based insurance program for medications used to treat three chronic conditions: asthma, hypertension, and diabetes. [27] The program was for employees and their dependents enrolled in the company's self-insured health benefit plan. [27] As part of the program, copayments were eliminated, and members paid 10% and 7.5% of the cost of retail and mail order prescriptions, respectively, for drugs used in the treatment of asthma, hypertension, and diabetes. [27] The program resulted in an increase in net payments for drugs used in the treatment of asthma, hypertension, and diabetes, but this increase was offset by a decrease in net payments for medical services specific or related to these conditions. [27] The offset was sufficient in the asthma and diabetes cohorts to produce a net savings in 2007 compared with 2004. [27]

Sponsors of Blue Cross Blue Shield of North Carolina administered plans

In January 2008, Blue Cross Blue Shield of North Carolina instituted a value-based insurance design program for medications to treat diabetes, hypertension, hyperlipidemia, and congestive heart failure. [28] Copayments for brand-name medications were lowered for all of the insurer's enrollees, while generic copayments were waived only for employers that opted into the program. [28] Adherence improved for enrollees, ranging from a gain of 3.8 percentage points for patients with diabetes to 1.5 percentage points for those taking calcium-channel blockers, when compared to others whose employers did not offer a similar program. [28]

See also

Related Research Articles

<span class="mw-page-title-main">Medicaid</span> United States social health care program for families and individuals with limited resources

In the United States, Medicaid is a government program that provides health insurance for adults and children with limited income and resources. The program is partially funded and primarily managed by state governments, which also have wide latitude in determining eligibility and benefits, but the federal government sets baseline standards for state Medicaid programs and provides a significant portion of their funding.

<span class="mw-page-title-main">Medicare (United States)</span> U.S. government health insurance for the old and disabled

Medicare is a government national health insurance program in the United States, begun in 1965 under the Social Security Administration (SSA) and now administered by the Centers for Medicare and Medicaid Services (CMS). It primarily provides health insurance for Americans aged 65 and older, but also for some younger people with disability status as determined by the SSA, including people with end stage renal disease and amyotrophic lateral sclerosis.

Prescription drug list prices in the United States continually are among the highest in the world. The high cost of prescription drugs became a major topic of discussion in the 21st century, leading up to the American health care reform debate of 2009, and received renewed attention in 2015. One major reason for high prescription drug prices in the United States relative to other countries is the inability of government-granted monopolies in the American health care sector to use their bargaining power to negotiate lower prices, and the American payer ends up subsidizing the world's R&D spending on drugs.

<span class="mw-page-title-main">Medicare Prescription Drug, Improvement, and Modernization Act</span>

The Medicare Prescription Drug, Improvement, and Modernization Act, also called the Medicare Modernization Act or MMA, is a federal law of the United States, enacted in 2003. It produced the largest overhaul of Medicare in the public health program's 38-year history.

The Federal Employees Health Benefits (FEHB) Program is a system of "managed competition" through which employee health benefits are provided to civilian government employees and annuitants of the United States government. The government contributes 72% of the weighted average premium of all plans, not to exceed 75% of the premium for any one plan.

The term managed care or managed healthcare is used in the United States to describe a group of activities intended to reduce the cost of providing health care and providing American health insurance while improving the quality of that care. It has become the predominant system of delivering and receiving American health care since its implementation in the early 1980s, and has been largely unaffected by the Affordable Care Act of 2010.

...intended to reduce unnecessary health care costs through a variety of mechanisms, including: economic incentives for physicians and patients to select less costly forms of care; programs for reviewing the medical necessity of specific services; increased beneficiary cost sharing; controls on inpatient admissions and lengths of stay; the establishment of cost-sharing incentives for outpatient surgery; selective contracting with health care providers; and the intensive management of high-cost health care cases. The programs may be provided in a variety of settings, such as Health Maintenance Organizations and Preferred Provider Organizations.

A copayment or copay is a fixed amount for a covered service, paid by a patient to the provider of service before receiving the service. It may be defined in an insurance policy and paid by an insured person each time a medical service is accessed. It is technically a form of coinsurance, but is defined differently in health insurance where a coinsurance is a percentage payment after the deductible up to a certain limit. It must be paid before any policy benefit is payable by an insurance company. Copayments do not usually contribute towards any policy out-of-pocket maximum, whereas coinsurance payments do.

<span class="mw-page-title-main">Medicare Part D</span> United States prescription drug benefit for the elderly and disabled

Medicare Part D, also called the Medicare prescription drug benefit, is an optional United States federal-government program to help Medicare beneficiaries pay for self-administered prescription drugs. Part D was enacted as part of the Medicare Modernization Act of 2003 and went into effect on January 1, 2006. Under the program, drug benefits are provided by private insurance plans that receive premiums from both enrollees and the government. Part D plans typically pay most of the cost for prescriptions filled by their enrollees. However, plans are later reimbursed for much of this cost through rebates paid by manufacturers and pharmacies.

Health care prices in the United States of America describe market and non-market factors that determine pricing, along with possible causes as to why prices are higher than in other countries.

Consumer-driven healthcare (CDHC), or consumer-driven health plans (CDHP) refers to a type of health insurance plan that allows employers and/or employees to utilize pretax money to help pay for medical expenses not covered by their health plan. These plans are linked to health savings accounts (HSAs), health reimbursement accounts (HRAs), or similar medical payment accounts. Users keep any unused balance or "rollover" at the end of the year to increase future balances or to invest for future expenses. They are a high-deductible health plan which has cheaper premiums but higher out of pocket expenses, and as such are seen as a cost effective means for companies to provide health care for their employees.

In the United States, a pharmacy benefit manager (PBM) is a third-party administrator of prescription drug programs for commercial health plans, self-insured employer plans, Medicare Part D plans, the Federal Employees Health Benefits Program, and state government employee plans. According to the American Pharmacists Association, "PBMs are primarily responsible for developing and maintaining the formulary, contracting with pharmacies, negotiating discounts and rebates with drug manufacturers, and processing and paying prescription drug claims." PBMs operate inside of integrated healthcare systems, as part of retail pharmacies, and as part of insurance companies.

The Medicare Part D coverage gap was a period of consumer payments for prescription medication costs that lied between the initial coverage limit and the catastrophic coverage threshold when the consumer was a member of a Medicare Part D prescription-drug program administered by the United States federal government. The gap was reached after a shared insurer payment - consumer payment for all covered prescription drugs reached a government-set amount, and was left only after the consumer had paid full, unshared costs of an additional amount for the same prescriptions. Upon entering the gap, the prescription payments to date were re-set to $0 and continued until the maximum amount of the gap was reached or the then current annual period lapses. In calculating whether the maximum amount of gap had been reached, the "True-out-of-pocket" costs (TrOOP) were added together.

In the United States, a high-deductible health plan (HDHP) is a health insurance plan with lower premiums and higher deductibles than a traditional health plan. It is intended to incentivize consumer-driven healthcare. Being covered by an HDHP is also a requirement for having a health savings account. Some HDHP plans also offer additional "wellness" benefits, provided before a deductible is paid. High-deductible health plans are a form of catastrophic coverage, intended to cover for catastrophic illnesses. Adoption rates of HDHPs have been growing since their inception in 2004, not only with increasing employer options, but also increasing government options. As of 2016, HDHPs represented 29% of the total covered workers in the United States; however, the impact of such benefit design is not widely understood.

<span class="mw-page-title-main">Drug coupon</span>

A drug coupon is a coupon intended to help consumers save money on pharmaceutical drugs. They are offered by drug companies or distributed to consumers via doctors and pharmacists, and most can be obtained online. There are drug coupons for drugs from many categories such as cholesterol, acne, migraine, allergies, etc.

An accountable care organization (ACO) is a healthcare organization that ties provider reimbursements to quality metrics and reductions in the cost of care. ACOs in the United States are formed from a group of coordinated health-care practitioners. They use alternative payment models, normally, capitation. The organization is accountable to patients and third-party payers for the quality, appropriateness and efficiency of the health care provided. According to the Centers for Medicare and Medicaid Services, an ACO is "an organization of health care practitioners that agrees to be accountable for the quality, cost, and overall care of Medicare beneficiaries who are enrolled in the traditional fee-for-service program who are assigned to it".

The Center for Medicare and Medicaid Innovation is an organization of the United States government under the Centers for Medicare and Medicaid Services (CMS). It was created by the Patient Protection and Affordable Care Act, the 2010 U.S. health care reform legislation. CMS provides healthcare coverage to more than 100 million Americans through Medicare, Medicaid, the Children’s Health Insurance Program (CHIP), and the Health Insurance Marketplace.

Balance billing, sometimes called surprise billing, is a medical bill from a healthcare provider billing a patient for the difference between the total cost of services being charged and the amount the insurance pays. It is a pervasive problem in the United States with providers who are out of network, and therefore not subject to the rates or terms of providers who are in-network. Balance billing has a variable prevalence by market and specialty.

Health care finance in the United States discusses how Americans obtain and pay for their healthcare, and why U.S. healthcare costs are the highest in the world based on various measures.

A hospital readmission is an episode when a patient who had been discharged from a hospital is admitted again within a specified time interval. Readmission rates have increasingly been used as an outcome measure in health services research and as a quality benchmark for health systems. Generally, higher readmission rate indicates ineffectiveness of treatment during past hospitalizations. Hospital readmission rates were formally included in reimbursement decisions for the Centers for Medicare and Medicaid Services (CMS) as part of the Patient Protection and Affordable Care Act (ACA) of 2010, which penalizes health systems with higher than expected readmission rates through the Hospital Readmission Reduction Program. Since the inception of this penalty, there have been other programs that have been introduced, with the aim to decrease hospital readmission. The Community Based Care Transition Program, Independence At Home Demonstration Program, and Bundled Payments for Care Improvement Initiative are all examples of these programs. While many time frames have been used historically, the most common time frame is within 30 days of discharge, and this is what CMS uses.

The Center for Value-Based Insurance Design at The University of Michigan is an advocate for development, implementation and evaluation of clinically nuanced health benefit plans and payment models. Since its inception in 2005, the V-BID Center has been actively engaged in understanding the impact of value-based insurance design (V-BID) on clinical outcomes and economic efficiency in the U.S. health care system. The V-BID Center also works with employers, consumer advocates, health plans, policy leaders, and academics to promote the implementation and demonstration of value-based insurance design in health benefit plans, as well as in state and federal legislation. Co-founded by A. Mark Fendrick, MD, and Michael Chernew, PhD, the V-BID Center is based in Ann Arbor, Michigan and operates collaboratively with the University of Michigan School of Public Health, the University of Michigan Medical School, and the University of Michigan Institute for Healthcare Policy and Innovation.

References

  1. ↑ "Medicare Advantage Value-Based Insurance Design Model". Centers for Medicare & Medicare Services. Archived from the original on 24 August 2016. Retrieved 12 April 2016.
  2. 1 2 3 Chernew, Michael (March 2007). "Value-Based Insurance Design". Health Affairs. 26 (2): w195–w203. doi:10.1377/hlthaff.26.2.w195. PMID   17264100 . Retrieved 12 April 2016.
  3. 1 2 3 4 5 6 "Value-Based Insurance Design". www.ncsl.org. Retrieved 12 April 2016.
  4. 1 2 3 4 "About V-BID". www.vbidcenter.org. Retrieved 12 April 2016.
  5. ↑ Chernew, Michael (January 2008). "Impact Of Decreasing Copayments On Medication Adherence Within A Disease Management Environment". Health Affairs. 27 (1): 103–112. doi:10.1377/hlthaff.27.1.103. PMID   18180484 . Retrieved 12 April 2016.
  6. ↑ Chernew, Michael (March 2010). "Evidence That Value-Based Insurance Can Be Effective". Health Affairs. 29 (3): 530–536. doi:10.1377/hlthaff.2009.0119. PMID   20093294 . Retrieved 12 April 2016.
  7. ↑ Hirth, Richard (April 2016). "Connecticut's Value-Based Insurance Plan Increased The Use of Targeted Services And Medication Adherence". Health Affairs. 35 (4): 637–646. doi: 10.1377/hlthaff.2015.1371 . PMID   27044964 . Retrieved 12 April 2016.
  8. 1 2 "Value-Based Benefit Design Introduction". NBCH Value-Based Purchasing Guide. National Business Coalition on Health. Retrieved 12 April 2016.
  9. 1 2 3 "The Asheville Project". NBCH Value-Based Purchasing Guide. National Business Coalition on Health. Retrieved 12 April 2016.
  10. ↑ Fendrick, Mark (September 2001). "A Benefit-Based Copay for Prescription Drugs: Patient Contribution Based on Total Benefits, Not Drug Acquisition Cost" (PDF). The American Journal of Managed Care. 7 (9): 861–867. PMID   11570020 . Retrieved 13 April 2016.
  11. 1 2 3 Hensley, Scott (16 June 2004). "From 'One Size Fits All' To Tailored Co-Payments". The Wall Street Journal. Retrieved 12 April 2016.
  12. 1 2 Sipkoff, Martin (October 2014). "Not So Much of a Reach: Let Sick Pay Less for Drugs". Managed Care Magazine. Retrieved 12 April 2016.
  13. ↑ "Value-Based Insurance Design: Shifting the Health Care Cost Discussion from How Much to How Well" (PDF). ihpi.umich.edu. Institute for Health Policy & Innovation. Retrieved 13 April 2016.
  14. ↑ Fendrick, Mark A.; Chernew, Michael E. (2006-12-14). "Value-based Insurance Design: Aligning Incentives to Bridge the Divide Between Quality Improvement and Cost Containment". The American Journal of Managed Care. 12 (Special Issue): SP5–SP10. PMID   17173492.
  15. 1 2 3 4 5 "Value-Based Insurance Design: Smart cost sharing can lead to better health at lower costs" (PDF). National Committee for Quality Assurance. Retrieved 14 April 2016.
  16. ↑ Legislatures, National Conference of State. "Value-Based Insurance Design". www.ncsl.org. Retrieved 2016-09-26.
  17. ↑ "Full Text of the Affordable Care Act and Reconciliation Act" (PDF). HealthCare. HealthCare.gov. Retrieved 14 April 2016.
  18. ↑ "Interim Final Rules for Group Health Plans and Health Insurance Issuers Relating to Coverage of Preventive Services Under the Patient Protection and Affordable Care Act" (PDF). Department of Health and Human Services. Retrieved 14 April 2016.
  19. 1 2 3 4 5 Hirth, Richard (April 2016). "Connecticut's Value-Based Insurance Plan Increased The Use Of Targeted Services And Medication Adherence". Health Affairs. 35 (4): 637–646. doi: 10.1377/hlthaff.2015.1371 . PMID   27044964 . Retrieved 14 April 2016.
  20. ↑ Kliff, Sarah (2013-08-28). "Michigan's bumpy road to expanding Medicaid". The Washington Post. The Washington Post. Retrieved 14 April 2016.
  21. ↑ "V-BID in Action: Michigan Medicaid Expansion". The Center for Value-Based Insurance Design. Retrieved 14 April 2016.
  22. 1 2 3 "Public Act 107 of 2013" (PDF). Michigan Legislature. Retrieved 14 April 2016.
  23. 1 2 3 Hanley, Sheila. "Announcement of Medicare Advantage Value-Based Insurance Design Model Test" (PDF). Center for Medicare & Medicaid Services. Retrieved 14 April 2016.
  24. ↑ Fuhrmans, Vanessa (May 10, 2004). "A Radical Prescription". The Wall Street Journal. Retrieved 18 April 2016.
  25. 1 2 3 Choudhry, Niteesh (November 2010). "At Pitney Bowes, Value-Based Insurance Design Cut Copayments And Increased Drug Adherence". Health Affairs. 29 (11): 1995–2001. doi:10.1377/hlthaff.2010.0336. PMID   21041738 . Retrieved 18 April 2016.
  26. 1 2 3 4 Shah, Nilay (November 2011). "Mayo Clinic Employees Responded To New Requirements For Cost Sharing By Reducing Possibly Unneeded Health Services Use". Health Affairs. 30 (11): 2134–2141. doi:10.1377/hlthaff.2010.0348. PMID   22068406 . Retrieved 18 April 2016.
  27. 1 2 3 4 5 Kelly, Emily (2009-11-01). "Value-Based Benefit Design and Healthcare Utilization in Asthma, Hypertension, and Diabetes". The American Journal of Pharmacy Benefits. 1 (4): 217–221. Retrieved 18 April 2016.
  28. 1 2 3 Maciejewski, Matthew (November 2010). "Copayment Reductions Generate Greater Medication Adherence In Targeted Patients". Health Affairs. 29 (11): 2002–2008. doi:10.1377/hlthaff.2010.0571. PMID   21041739 . Retrieved 18 April 2016.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.